M&I Teresa O'Meara is a recipient of of the Investigators in the Pathogenesis of Infectious Disease (PATH) program of the Burroughs Wellcome Fund. Her lab will further study the mechanisms of attachment and virulence for C. auris, with a focus on how the novel adhesin contributes to pathogenesis. On a practical level, their work will suggest strategies for developing vaccine candidates and therapeutics to limit disease caused by this emerging pathogen.

On May 16, 2024, the Regents of the University of Michigan promoted Melanie Pearson, Ph.D., to Associate Professor on the Research Track, effective September 1, 2024.

Faith Anderson, Jaime Fuentes, and Andrés Rivera Ruiz, M&I Ph.D. candidates, have been awarded prestigious fellowships from Rackham Graduate School, in recognition of their academic excellence. Congratulations, we’re so proud of you!

In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.

A research team, led by Michigan Medicine and in partnership with Hurley Medical Center, finds that nearly three-quarters of patients at a clinic in Flint, Mich., a community that is predominantly Black and socioeconomically disadvantaged, had neuropathy — of which 75% was undiagnosed.

A study builds on previous work that found depriving T cells of iron prevented cells from proliferating. The current study, published in PNAS, found that excess iron is just as problematic.

Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.

Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X

Four Graduate Program in Immunology alumni participated in a panel discussion about their career paths.

This M&I award recognizes outstanding dissertations.

Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.

Four faculty and two staff members from the departments of Anesthesiology, Neurology, Radiology and Surgery, and the Office of Graduate Medical Education (GME), are recipients of GME Awards for 2024

Among people with multiple sclerosis in the United States, more than half experienced at least one fall in a six-month period and approximately one-third of those falls resulted in an injury.

M&I grant administration team attends and presents at the National Council for University Research Administrators (NCURA) conferences

A Michigan Medicine study finds that storing chemicals in a garage at home may associate with an increased risk of ALS.